Drug class
Bisquinoline antimalarial; blood-schizonticidal agent
Mechanism of action
A bisquinoline antimalarial that interferes with haem detoxification in Plasmodium parasites, leading to accumulation of toxic haem species and parasite death. It is used clinically in combination with dihydroartemisinin; phosphate is a salt component, not a distinct active target.
General use cases
- Treatment of uncomplicated Plasmodium falciparum malaria as part of the fixed-dose dihydroartemisinin–piperaquine combination, in accordance with current national malaria guidelines and resistance patterns
Piperaquine is the antimalarial active moiety; phosphate is the salt component. It is usually used as part of a dihydroartemisinin–piperaquine combination; the combination partner and regimen, not the phosphate counter-ion, determine the combination indication.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
